-
Study aim
-
Comparison of dexmedetomidine and propofol for maintaining anesthesia during cataract surgery
-
Design
-
The clinical trial has a control group, with parallel groups, double-blind, Random allocation by permutation block method, phase 2 on 60 patients. For randomization, permutation blocks of six will be used.
-
Settings and conduct
-
This study will be conducted on the population of people with cataracts admitted to Heshmatieh Sabzevar Hospital. Patients are randomly assigned into three treatment groups using permutation blocks of six: propofol group, dexmedetomidine, and control group. Routine treatment is considered for the control group. Then, in the first group, dexmedetomidine is added to routine intravenous drugs, and in the second group, propofol is added to routine intravenous drugs. Hemodynamic symptoms (BP, PR, SPO2) are monitored in 5 time periods, including admission to the operating room, before anesthesia, immediately after, 15 minutes later, and during recovery. In addition, blinding is done in a double-blind manner (therapist and the outcome assessor).
-
Participants/Inclusion and exclusion criteria
-
obtaining informed consent, At least 60 years old, the absence of other eye diseases؛ the lack of drug sensitivity, the absence of underlying diseases
-
Intervention groups
-
Three treatment groups include propofol, dexmedetomidine, and a control group
-
Main outcome variables
-
Complications after anesthesia (nausea, dizziness, etc.); the length of time the patient remains in recovery; the amount of receiving narcotic painkillers; incidence and severity of delirium; Duration of patient sedation during cataract surgery